Nidan Laboratories and Healthcare IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 18, 2022Let’s have a detailed review of the company and analytics of the Nidan Laboratories and Healthcare IPO release date, IPO offer price, subscription, Nidan Laboratories and Healthcare Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
Face Value | Rs 10 |
Price Band | Rs 125 |
Listing At | NSE Emerge |
Min. Order Quantity | 1000 Shares |
Listing Date | Nov 12, 2021 |
Offer for Sale | Rs Lakh |
Fresh Issue | Rs Lakh |
IPO Size | Rs 5,000 Lakh |
Tick Size | 1 |
Nidan Laboratories and Healthcare IPO are listed at a [●] premium. Check out the live share price by clicking on the below link.
Nidan Laboratories and Healthcare IPO – Summary
Their Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000, under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra.
Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratories And Healthcare Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by their shareholders at the EGM held on February 26, 2021, and had obtained a fresh certificate of incorporation dated March 24, 2021, issued by the Registrar of Companies, Maharashtra. Subsequently, their Company was converted into a public limited company and the name of their Company was changed to ‘Nidan Laboratories And Healthcare Limited’
The Promoter of this company is DR. NITHIN VITTHALRAO THORAVE. The lead manager to the issue is FIRST OVERSEAS CAPITAL LIMITED, and the Registrar to this issue is BIG SHARE SERVICES PRIVATE LIMITED.
Nidan Laboratories and Healthcare IPO Date
The opening and the closing date of Nidan Laboratories and Healthcare IPO are Oct 28, 2021, and Nov 2, 2021.
Nidan Laboratories and Healthcare IPO Subscription
Day / Date | NII | RII | Total Subscription |
1st Day – 28th Oct | 0.01x | 1.13x | 0.57x |
2nd Day – 29th Oct | 0.02x | 1.81x | 0.91x |
3rd Day – 1st Nov | 0.14x | 2.74x | 1.44x |
4th Day – 2nd Nov | 0.15x | 3.44x | 1.80x |
Shares Offered or Net Issue | 1,900,000 | 1,900,000 | 3,800,000 |
The shares subscribed by the public will be updated here.
Check Nidan Laboratories and Healthcare IPO LIVE Subscription
- Nidan Laboratories and Healthcare IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Nidan Laboratories and Healthcare IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
Nidan Laboratories and Healthcare Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
Basis of Allotment Finalization | Nov 9, 2021 |
Refunds Initiation | Nov 10, 2021 |
Credit of Shares to Demat Account | Nov 11, 2021 |
Share Listing Date | Nov 12, 2021 |
Nidan Laboratories and Healthcare IPO Price
The face value of each share is Rs.10, but the price band of the IPO is Rs.125
Nidan Laboratories and Healthcare IPO Size
This Initial Public Issue of 40,00,000 Equity Shares of Rs.10 each for cash at a price of Rs.125 per equity share aggregating to Rs.5,000 Lakh.
Nidan Laboratories and Healthcare IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.10/ each.
Issue Size: 40,00,000 Equity Shares of Rs.10 each, aggregating to Rs.5,000 Lakh
Open Free Demat Account Now!
Nidan Laboratories and Healthcare IPO – Live Performance
The listing date of this IPO is Nov 12, 2021. You can check the live performance of the IPO here, only after it is listed on exchanges.
Live IPO Performance – Nidan Laboratories and Healthcare Share Price |
Nidan Laboratories and Healthcare IPO Grey Market Premium
The Nidan Laboratories and Healthcare Limited IPO Grey Market Premium price are Rs X, the Kostak rate is Rs X and the Subject to Sauda is X.
Nidan Laboratories and Healthcare IPO – Company Overview
Nidan was established as a Proprietary Firm in 1994 by their Promoter- Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services were provided under one roof at reliable and affordable price. The business was carried out under sole proprietorship, which was later taken over by their Company in 2000.
From the year 2000, he expanded the diagnostic business by setting up various centres within the Northern District of Mumbai and Pune and Southern District of Pune. As of this date, 30 diagnostic cum collection centres are operational under the brand name of “Nidan Healthcare” and offer radiology, neurology, cardiology, dental as well as pathology services.
Out of the 35 centres, 16 centre’s are under the Franchisee model where 1 centre acts as a fully operated diagnostic centre and 15 centre’s act solely as standalone collection centres. They provide integrated diagnostics services to more than 1 Lakh patients per year. Since 2000, private and government hospitals have been using their services and diagnostics centres for various pathology and radiology tests.
After more than a decade of experience, they have successfully set their diagnostics centre in Asian Heart Hospital, Mumbai under the name of “Asian Nidan Imaging Centre”. To enable their patients to easily distinguish their pathology and radiology services, they introduced “NIDANPATH” and “NIDAN DIAGNOSTICS” respectively in the year 2017.
Nidan Laboratories and Healthcare IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
Amount (in INR & Lakh) | ||||
30-June-21 | 31-Mar-21 | 31-Mar-20 | Mar-19 | |
Total Assets | 3296.74 | 3151.66 | 2432.76 | 1899.74 |
*Total Revenue | 784.58 | 2185.32 | 2219.18 | 2097.22 |
Total Expense | 644.27 | 1855.09 | 2147.72 | 2074.87 |
Profit After Tax | 108.74 | 230.24 | 71.46 | 22.35 |
Earnings per Equity Share (in Lakh)
31-Mar-21 | 31-Mar-20 | Mar-19 | |
Basic & Diluted | 2.32 | 0.72 | 0.23 |
Further, their PAT for the period ended on March 31, 2021, March 31, 2020, and March 31, 2019, were Rs. 230.24 Lakh, Rs. 71.46 Lakh, and Rs. 22.35 Lakh respectively.
Nidan Laboratories and Healthcare IPO – Promoters
The Promoter of this company is:
- DR. NITHIN VITTHALRAO THORAVE
List of Related Parties (Key Managerial Personnel)
- Edwin Francis Dabre, Executive Director
- Tejal Anil Jayakar, Executive Director & CFO
- Krupesh Deepak Thakur, Non-Executive Director
- Nilesh Ghanshyam Bide Non-Executive Independent Director
- Abhinay Shashikant Nerurkar, Non-Executive Independent Director
- Karim Hakam Khimani, Non-Executive Independent Director
Nidan Laboratories and Healthcare IPO – Promoters Holding
- Pre Issue Share Holding – %
- Pos Issue Share Holding – %
Nidan Laboratories and Healthcare IPO Offer Details or Issue Details
Particulars | No. Of Equity Shares |
Equity Shares Offered | Up to 40,00,000 Equity Shares aggregating up to Rs.50,00,00,000 |
of which: | |
Issue Reserved for the Market Makers | Up to 2,00,000 Equity Shares aggregating up to Rs.2,50,00,000 |
Net Issue to the Public | Up to 38,00,000 Equity Shares aggregating up to Rs.47,50,00,000 |
Of which: | |
Retail Investors Portion | Not less than 19,00,000 Equity Shares |
Other than Retail Individual Investors | Not more than 19,00,000 Equity Shares |
Equity Shares outstanding prior to the Issue | 9900,000 Equity Shares |
Equity Shares outstanding after the Issue | 1,39,00,000 Equity Shares |
Nidan Laboratories and Healthcare IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
1. Repayment / pre-payment, in full or in part, of certain borrowings availed by their Company;
2. Additional Working Capital; and
3. General Corporate Expenses.
Nidan Laboratories and Healthcare IPO – Business Strategy
- Focusing on increasing reach within PAN Mumbai and PAN India
- Continue to Focus on Providing Customer-Centric Services and Offerings
- Expand their offerings of diagnostic sources with focuses on splendid diagnostic services
- Branding & Advertising
Nidan Laboratories and Healthcare IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Established brand name
- Customer-Centric Services
- Location Benefit
- One-Stop Solution at Affordable Price
- Robust Technical Capability and State of the Art Technology with Strong IT Infrastructure
- Dedicated Management Team with Significant Industry Experience
The relevant quantitative factors are:
Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
31-Mar-21 | 2.32 | 0.17 | 13.46 |
31-Mar-20 | 0.72 | 0.06 | – |
Mar-19 | 0.23 | 0.02 | – |
Nidan Laboratories and Healthcare IPO: Competitive Peers
Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | NAV (Rs.) | |
Nidan Laboratories and Healthcare Limited | 10 | 53.88 | 2.32 | 0.17 | 13.46 |
Listed Peers | |||||
Metropolis Healthcare Limited | 2 | 55.73 | 35.97 | 25.91 | 2807.00 |
Dr. Lal PathLabs Limited | 10 | 82.18 | 35.33 | 23.42 | 3704.95 |
Nidan Laboratories and Healthcare IPO Lead Managers
Lead Managers |
FIRST OVERSEAS CAPITAL LIMITED 1-2 Bhupen Chambers, Ground Floor, Dalal Street, Mumbai-400 001 Tel. No.: +91 22 40509999 Fax No.: N.A. Email: satish@focl.in/ mala@focl.in Investor Grievance Email: investorcomplaints@focl.in Website: www.focl.in Contact Person: Mr. Satish Sheth/ Ms. Mala Soneji SEBI Registration No.: INM000003671 |
Nidan Laboratories and Healthcare IPO Registrar to offer
Registrar to the Offer |
Bigshare Services Private Limited Bharat Tin Works Building, 1st Floor, Opp. Vasant Oasis, Makwana Road, Marol, Andheri (East), Mumbai – 400059, Maharashtra, India. Tel. No.: +91 22 62638200 Fax No.: +91 22 62638299 E-mail: ipo@bigshareonline.com Investor Grievance Email: investor@bigshareonline.com Website: www.bigshareonline.com Contact Person: Mr. Babu Raphel SEBI Registration No.: INR000001385 |
Nidan Laboratories and Healthcare IPO – Other Details
- Statutory Auditor – M/s R. K. Chapawat & Co, Chartered Accountants
- Legal Counsel to the Company – NA
- Bankers to the Company – NA
Nidan Laboratories and Healthcare IPO Review by Stock Brokers
Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Nidan Laboratories and Healthcare IPO
Nidan Laboratories and Healthcare Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
Nidan Laboratories and Healthcare IPO Review FAQs
Ques – What is the Issue Size of Nidan Laboratories and Healthcare IPO?
Answer – The Company is making an initial public offer of 40,00,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
Ques – What is the Price band of Nidan Laboratories and Healthcare IPO?
Answer – The price band for this particular IPO ranges between Rs 125. As far as the face value of the share is of concern, it is Rs.10 per share.
Ques – What is the Nidan Laboratories and Healthcare IPO Open Date?
Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on Oct 28, 2021, while the closing date is set at Nov 2, 2021.
Ques – What is the Nidan Laboratories and Healthcare IPO Allotment Date?
Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Nov 09, 2021, refund initiation is on Nov 10, 2021, credit of shares is on Nov 11, 2021, and share listing date is on Nov 12, 2021.
Ques – What is the Nidan Laboratories and Healthcare IPO Listing Date?
Answer – Shares of this company shall be listed in the exchanges on Nov 12, 2021. The date, when the listing would be done, is stagnant on Nov 12, 2021.
Ques – Who is the Registrar of Nidan Laboratories and Healthcare IPO?
Answer – One of the reputed registrars is managing the issue of this IPO, i.e. Bigshare Services Private Limited. Their website will help you regarding the further information you are on the lookout for.
Ques – Who is the Promoter of Nidan Laboratories and Healthcare IPO?
Answer – Here are the promoters of this IPO – DR. NITHIN VITTHALRAO THORAVE. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
Ques – What is the GMP of Nidan Laboratories and Healthcare IPO?
Answer – They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Ques – Is Nidan Laboratories and Healthcare IPO good for Investment?
Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
Ques – What is the PAT of Nidan Laboratories and Healthcare Company?
Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Lakh is 230.24, 2020 is 71.46, 2019 is 22.35. PAT from June 2021 is 108.74.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics